Available
Specifications
Manufacturer: Nichi-Iko Pharmaceutical Co., Ltd.
Active ingredient:
Shelf life: 3 years (36 months) from the date of manufacture, subject to storage conditions.
Current price
$70
Place an order
Want to find several options? Our manager will clarify all the details of your order and choose a convenient delivery option
Delivery and self-delivery
Storage conditions
Store at a temperature not exceeding 25°C.
Protect from direct sunlight and strong heat.
Do not freeze.
Keep out of reach of children.
Nichiphargen Injection contains sodium heparin, a direct-acting anticoagulant used for the prevention and treatment of thromboembolic diseases.
Indications for Use:
- Prevention and Treatment of Thromboembolic Diseases:
- Deep vein thrombosis (DVT).
- Pulmonary embolism (PE).
- Thrombophlebitis.
- Prevention of Blood Clotting:
- During hemodialysis.
- In cardiovascular surgery and other vascular procedures.
- In laboratory settings.
Contraindications:
- Hypersensitivity to heparin or any components of the drug.
- Active Bleeding or conditions with a high risk of bleeding.
- Heparin-Induced Thrombocytopenia (HIT).
- Severe hepatic or renal failure.
- Uncontrolled arterial hypertension.
- Recent surgical procedures involving the brain, spinal cord, or eyes.
Side Effects:
- Bleeding:
- Of various localizations and severities.
- Thrombocytopenia:
- Decrease in platelet count, including heparin-induced thrombocytopenia.
- Allergic Reactions:
- Skin rash, pruritus (itching), urticaria (hives), and rare anaphylactic reactions.
- Osteoporosis:
- Associated with prolonged use.
- Liver Function:
- Elevated liver enzyme levels.
Special Instructions:
- Therapy Monitoring:
- Regular monitoring of blood coagulation parameters (e.g., activated partial thromboplastin time [aPTT]) and platelet counts is required.
- Drug Interactions:
- Use with caution when combined with other anticoagulants, antiplatelet agents, or nonsteroidal anti-inflammatory drugs (NSAIDs), as the risk of bleeding increases.
- Pregnancy and Lactation:
- Use only under strict medical indications and close supervision by a healthcare provider.
- Consultation Required:
- Before initiating treatment with Nichiphargen Injection, consult a physician to evaluate the appropriateness of therapy and determine the optimal dosage. Self-medication is strongly discouraged and may result in severe adverse effects.
- Injection solution in 20 ml polyethylene vials.
- Intended for intravenous administration (as a drip infusion or jet, depending on the indications).
- Release form - sterile injection solution.
